Literature DB >> 29728924

The impact of deep surgical site infection on surgical outcomes after posterior adult spinal deformity surgery: a matched control study.

Sleiman Haddad1,2, Susana Núñez-Pereira3, Carlos Pigrau4, Dolors Rodríguez-Pardo4, Alba Vila-Casademunt5, Ahmet Alanay6, Emre R Acaroglu7, Frank S Kleinstueck8, Ibrahim Obeid9, Francisco Javier Sanchez Perez-Grueso10, Ferran Pellisé4.   

Abstract

PURPOSE: The impact of deep surgical site infection (SSI) on surgical outcomes after adult spinal deformity (ASD) surgery is still unclear. We aimed to study the morbidity of SSI in ASD and its impact on deformity correction and functional outcome.
METHODS: Prospective multicenter matched-cohort study including consecutively enrolled ASD patients. Patients developing SSI were matched to similar controls in terms of age, gender, ASA, primary or revision, extent of fusion, and use of tri-columnar osteotomies. Preoperative parameters, surgical variables, and complications were recorded. Deformity parameters and Health Related Quality of Life (HRQoL) scores were obtained preoperatively and at 6, 12, and 24 months. Independent t test and Fischer's exact test were used for comparisons.
RESULTS: 444 surgical ASD patients with more than 2 years of follow-up were identified. 20 sustained an acute SSI and 60 controls were accordingly matched. No differences were observed between groups in preoperative radiological and HRQoL variables confirming comparable groups. SSI patients had longer hospital stay and more mechanical complications including proximal junctional kyphosis. Infection was associated with more unrelated complications and revisions. Deformity correction was maintained equally at the different time intervals. One death was related to SSI. SSI patients had worse overall HRQoL status at 1 year and were less likely to experience improvement. However, no significant differences were recorded thereafter.
CONCLUSION: SSI significantly affects the first postoperative year after posterior ASD surgery. It is associated with more complications, unrelated revisions, and worst quality of life. However it's negative impact seems to be diluted by the second postoperative year as differences in HRQoL scores between the two groups decrease. These slides can be retrieved under Electronic Supplementary material.

Entities:  

Keywords:  Adult spinal deformity; Clinical outcome; Complication; Deep surgical site infection; Scoliosis; Surgery

Mesh:

Year:  2018        PMID: 29728924     DOI: 10.1007/s00586-018-5583-3

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  28 in total

1.  Implant survival after deep infection of an instrumented spinal fusion.

Authors:  S Núñez-Pereira; F Pellisé; D Rodríguez-Pardo; C Pigrau; J Bagó; C Villanueva; E Cáceres
Journal:  Bone Joint J       Date:  2013-08       Impact factor: 5.082

Review 2.  Impact of spine surgery complications on costs associated with management of adult spinal deformity.

Authors:  Samrat Yeramaneni; Chessie Robinson; Richard Hostin
Journal:  Curr Rev Musculoskelet Med       Date:  2016-09

3.  Safety and efficacy of osteotomies in adult spinal deformity: what happens in the first year?

Authors:  Selim Ayhan; Bilal Aykac; Selcen Yuksel; Umit Ozgur Guler; Ferran Pellise; Ahmet Alanay; Francisco Javier Sanchez Perez-Grueso; Emre Acaroglu
Journal:  Eur Spine J       Date:  2015-05-07       Impact factor: 3.134

4.  The Core Outcome Measures Index (COMI) is a responsive instrument for assessing the outcome of treatment for adult spinal deformity.

Authors:  A F Mannion; A Vila-Casademunt; M Domingo-Sàbat; S Wunderlin; F Pellisé; J Bago; E Acaroglu; A Alanay; F S Pérez-Grueso; I Obeid; F S Kleinstück
Journal:  Eur Spine J       Date:  2015-10-30       Impact factor: 3.134

5.  Risk factors for implant removal after spinal surgical site infection.

Authors:  Naoya Tsubouchi; Shunsuke Fujibayashi; Bungo Otsuki; Masanori Izeki; Hiroaki Kimura; Masato Ota; Takeshi Sakamoto; Akira Uchikoshi; Shuichi Matsuda
Journal:  Eur Spine J       Date:  2017-09-14       Impact factor: 3.134

6.  Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee.

Authors:  A J Mangram; T C Horan; M L Pearson; L C Silver; W R Jarvis
Journal:  Am J Infect Control       Date:  1999-04       Impact factor: 2.918

7.  Complications and intercenter variability of three-column osteotomies for spinal deformity surgery: a retrospective review of 423 patients.

Authors:  Kristina Bianco; Robert Norton; Frank Schwab; Justin S Smith; Eric Klineberg; Ibrahim Obeid; Gregory Mundis; Christopher I Shaffrey; Khaled Kebaish; Richard Hostin; Robert Hart; Munish C Gupta; Douglas Burton; Christopher Ames; Oheneba Boachie-Adjei; Themistocles S Protopsaltis; Virginie Lafage
Journal:  Neurosurg Focus       Date:  2014-05       Impact factor: 4.047

8.  Effect of deep wound infection following lumbar arthrodesis for degenerative disc disease on long-term outcome: a prospective study: clinical article.

Authors:  Asdrubal Falavigna; Orlando Righesso; Vincent C Traynelis; Alisson Roberto Teles; Pedro Guarise da Silva
Journal:  J Neurosurg Spine       Date:  2011-06-17

9.  The impact of perioperative complications on clinical outcome in adult deformity surgery.

Authors:  Steven D Glassman; Christopher L Hamill; Keith H Bridwell; Frank J Schwab; John R Dimar; Thomas G Lowe
Journal:  Spine (Phila Pa 1976)       Date:  2007-11-15       Impact factor: 3.468

10.  Risk factors for unavoidable removal of instrumentation after surgical site infection of spine surgery: A retrospective case-control study.

Authors:  Hiroyuki Tominaga; Takao Setoguchi; Hideki Kawamura; Ichiro Kawamura; Satoshi Nagano; Masahiko Abematsu; Fumito Tanabe; Yasuhiro Ishidou; Takuya Yamamoto; Setsuro Komiya
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

View more
  6 in total

1.  A prediction model of surgical site infection after instrumented thoracolumbar spine surgery in adults.

Authors:  Daniël M C Janssen; Sander M J van Kuijk; Boudewijn d'Aumerie; Paul Willems
Journal:  Eur Spine J       Date:  2019-01-07       Impact factor: 3.134

2.  Effect of Serious Adverse Events on Health-related Quality of Life Measures Following Surgery for Adult Symptomatic Lumbar Scoliosis.

Authors:  Justin S Smith; Christopher I Shaffrey; Michael P Kelly; Elizabeth L Yanik; Jon D Lurie; Christine R Baldus; Charles Edwards; Steven D Glassman; Lawrence G Lenke; Oheneba Boachie-Adjei; Jacob M Buchowski; Leah Y Carreon; Charles H Crawford; Thomas J Errico; Stephen J Lewis; Tyler Koski; Stefan Parent; Han Jo Kim; Christopher P Ames; Shay Bess; Frank J Schwab; Keith H Bridwell
Journal:  Spine (Phila Pa 1976)       Date:  2019-09-01       Impact factor: 3.241

3.  Therapeutic effect of ethylenediaminetetraacetic acid irrigation solution against wound infection with drug-resistant bacteria in a rat model: an animal study.

Authors:  Z Deng; F Liu; C Li
Journal:  Bone Joint Res       Date:  2019-06-05       Impact factor: 5.853

4.  Does local vancomycin powder impregnated with autogenous bone graft and bone substitute decrease the risk of deep surgical site infection in degenerative lumbar spine fusion surgery?-An ambispective study.

Authors:  Po-Hsin Chou; Hsi-Hsien Lin; Yu-Cheng Yao; Ming-Chau Chang; Chien-Lin Liu; Shih-Tien Wang
Journal:  BMC Musculoskelet Disord       Date:  2022-09-10       Impact factor: 2.562

5.  Clinical relevance of occult infections in spinal pseudarthrosis revision.

Authors:  Marco D Burkhard; Ali Hassanzadeh; Octavian Andronic; Tobias Götschi; Ilker Uçkay; Mazda Farshad
Journal:  N Am Spine Soc J       Date:  2022-09-21

6.  Conditions for Achieving Postoperative Pelvic Incidence-Lumbar Lordosis < 10° in Circumferential Minimally Invasive Surgery for Adult Spinal Deformity.

Authors:  Masayuki Ishihara; Shinichirou Taniguchi; Takashi Adachi; Yoichi Tani; Masaaki Paku; Muneharu Ando; Takanori Saito
Journal:  J Clin Med       Date:  2022-03-13       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.